Abstract: Composition and method for irrigating a prepared dental root canal. The composition is an aqueous composition of ethylenediamine tetraacetic acid, chlorhexidine or orally acceptable addition salt, and N-cetyl-N,N,N-trimethylammonium bromide, and is effective for simultaneous smear layer removal and disinfection.

Abstract: Herein are provided derivatized hyperbranched polyglycerols (“dHPGs”). The dHPG comprises a core comprising a hyperbranched polyglycerol derivatized with C1C20 alkyl chains and a shell comprising at least one hydrophilic substituent bound to hydroxyl groups of the core, wherein the hyperbranched polyglycerol comprises from about 1 to about 200 moles of the at least one hydrophilic substituent. The dHPGs are for use as agents for the delivery of a drug or other biologically active moiety to the urinary tract, the digestive tract, the airways, the vaginal cavity and cervix and the peritoneal cavity to treat indications such as cancer, which may be useful in the treatment of or the manufacture of a medicament, in the preparation, of a pharmaceutical composition for the treatment of cancer, as a pre-treatment or co-treatment to improve drug uptake in a tissue. Furthermore, there are provided methods of making dHPGs.

Abstract: The present invention relates to compositions and methods of use thereof for cancer therapy sensitization. Such compositions comprise functional fragments of the nucleotide and/or polypeptide sequences of a Secreted Protein Acidic and Rich in Cysteine (SPARC). The compositions can be used in combination with existing chemotherapeutic agents for treatment of cancers.

Abstract: Particular naturally occurring glycosylated acyl-flavonols are now shown to be effective mammalian ?-amylase inhibitors. Such compounds can be obtained from plants of the genus Crocosmia and the compounds are useful in controlling starch digestion such as for management of glycemia in pre-diabetic or diabetic subjects, for management of obesity or for inhibiting oral caries or plaque formation.

Abstract: A method for identifying a subject being at risk for or having a chronic inflammatory disease, fibrillinopathy, atherosclerosis, or coronary artery disease is provided. The method may include determining the concentration of GrA and/or GrB in a blood or serum sample from said subject; and comparing the concentrations to the corresponding concentration in a control sample, wherein an elevated concentration of GrA and/or GrB may be indicative of a chronic inflammatory disease, fibrillinopathy, atherosclerosis, or coronary artery disease. The method may further include identifying concentrations of fibrinogen, elastin and/or fibrillin.

Abstract: Described herein are a method and apparatus for determining viscoelastic parameters of a tissue. A vibration signal is applied to the tissue and displacements at a plurality of locations within the tissue are measured at a plurality of times. The viscoelastic parameters of the tissue, including elasticity and viscosity, can then be determined by fitting a finite element model of the tissue to the vibration signal and the measured displacements and by solving for the viscoelastic parameters of the model. A value for density of each element of the model is selected and the absolute values for the viscoelastic parameters of each of the elements in the model is determined. Alternatively, the difference in relaxation-times between two locations within the tissue can be determined from the difference in phases of the strains at the two locations.

Abstract: The present invention provides methods of detecting mutations in a GNA11 gene in a melanocytic neoplasm for diagnostic and prognostic purposes. The invention further provides methods of treating such melanocytic neoplasm by modulating the activity of the mutated GNA11 gene.

Abstract: Bispecific antisense oligonucleotides which consist essentially of a sequence of bases that is complementary to portions of both the gene encoding human IGFBP-2 and the gene encoding human IGFBP-5 are useful in as antisense therapeutics in the treatment of endocrine-regulated cancers.

Abstract: Isolated polynucleotides comprising an MKI67 mini-promoter are provided. The mini-promoter may be operably linked to an expressible sequence, e.g. reporter genes, genes encoding a polypeptide of interest, regulatory RNA sequences such as miRNA, siRNA, anti-sense RNA, etc., and the like. In some embodiments a cell comprising a stable integrant of an expression vector is provided, which may be integrated in the genome of the cell. The mini-promoter may also be provided in a vector, for example in combination with an expressible sequence. The polynucleotides find use in a method of expressing a sequence of interest, e.g. for identifying or labeling cells, monitoring or tracking the expression of cells, etc.

Abstract: Isolated polynucleotides comprising a PITX3 promoter are provided, where a PITX3 regulatory element is operably joined to a PITX3 basal promoter utilizing a non-native spacing between the promoter and regulatory elements. The promoter may be operably linked to an expressible sequence, e.g. reporter genes, genes encoding a polypeptide of interest, regulatory RNA sequences such as miRNA, siRNA, anti-sense RNA, etc., and the like. In some embodiments a cell comprising a stable integrant of an expression vector is provided, which may be integrated in the genome of the cell. The promoter may also be provided in a vector, for example in combination with an expressible sequence. The polynucleotides find use in a method of expressing a sequence of interest, e.g. for identifying or labeling cells, monitoring or tracking the expression of cells, etc.

Abstract: Compounds having a structure of Formula I: or a pharmaceutically acceptable salt or stereoisomer thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10 and R11 are as defined herein, and wherein at least one of R1, R2, R3, R4 or R5 is F, are provided. Uses of such compounds for treatment of various indications, including prostate cancer as well as methods of treatment involving such compounds are also provided.

Abstract: Administration of antisense oligodeoxynucleotides (ODN) targeted against the testosterone-repressed prostate message-2 (TRPM-2) gene can reduce the amount of TRPM-2 in renal cell cancer (RCC) cells and other cancer cells, and as a result enhance chemosensitivity of these cells to chemotherapy agents and radiation. Thus, for example, the sensitivity of renal cell cancer cells to a chemotherapeutic agent can be increased by exposing renal cell cancer cells to a chemotherapeutic agent and an agent which reduces the amount of TRPM-2 in the renal cell cancer cells. This provides an improved method for treatment of renal cell cancer, which is generally resistant to treatment with known chemotherapy agents.

Abstract: Embodiments presented herein relate to various polymers. Some of the polymer embodiments are heparin binding polymers. Some embodiments of the heparin binding polymers can be employed to bind to heparin for methods such as separating, purifying, removing, and/or isolating heparin and heparin like molecules.

Abstract: A lipid particle can include a plurality of cationic lipids, such as a first cationic lipid and a second cationic lipid. The first cationic lipid can be selected on the basis of a first property and the second cationic can be selected on the basis of a second property. The first and second properties are complementary. The attributes of the lipid particle can reflect the selected properties of the cationic lipids, and the complementary nature of those properties.

Abstract: A 3D structure approximating a 3D curved surface having non-zero Gaussian curvature over a portion of the surface. The structure is formed of a plurality of thin strips (10) which are simply deformed and aligned adjacent one another to approximate the 3D curved surface. Each strip has: zero Gaussian curvature; a strip width which varies by no more than ±10% along a longitudinal axis of the strip; and a predetermined flat shape such that, after simple deformation, adjacent edges of adjacent strips can be aligned substantially parallel to one another separated by a substantially small gap. The aligned, simply deformed strips appear straight when viewed from a preferred viewing direction. The strips can be attached to a rigid support (12) at selected mounting points such that natural equilibrium deformation between the mounting points holds the aligned simply deformed strips in a desired approximation of the 3D curved surface.

Abstract: The present invention relates generally to peptides and more specifically to antimicrobial and immunomodulatory host defense peptides.

Abstract: Embodiments presented herein relate to various polymers. Some of the polymer embodiments are heparin binding polymers. Some embodiments of the heparin binding polymers can be employed to bind to heparin for methods such as separating, purifying, removing, and/or isolating heparin and heparin like molecules.

Abstract: Prostate cancer comes in various forms and has proven difficult to treat. Provided herein are various methods and compositions for treating all forms of prostate cancers with dopa decarboxylase (DDC) inhibitors. These dopa decarboxylase inhibitors include carbidopa (?-Methyl-dopahydrazine), MFMD (?-monofluoromethyldopa), NSD-1015 (3-hydroxybenzylhydrazine), Methyldopa (L-?-Methyl-3,4-dihydroxyphenylalanine) or benserazide, and the inhibitors may be used in combination. DDC inhibitors may also be used to inhibit the progression of prostate cancer to androgen-independence and neuroendocrine prostate cancer.

Abstract: The present invention relates to a method and apparatus for imaging the mechanical properties of a tissue region from within an endocavity of a patient. The apparatus generally comprises an ultrasound probe, a vibration assembly translationally coupled to probe and operable to vibrate the probe along a vibration plane, and a rotation assembly rotationally coupled to the vibration assembly and operable to rotate the probe and vibration assembly about a selected rotational range. The method generally comprises inserting an ultrasound probe into an endocavity of a patient, vibrating the probe along a vibration plane thereby causing deformational excitement of a tissue region contacted by the probe, capturing a first series of ultrasound images of the tissue region, rotating the vibration plane relative to the tissue region by a selected angular rotation, and capturing a second series of ultrasound images of the tissue region.

Abstract: Disclosed is a method and corresponding fuel injector for injecting gaseous and liquid fuel into an engine. The method comprises delivering a liquid fuel to a fuel injector, delivering a pressurized gaseous fuel to the fuel injector, entraining the liquid fuel within the gaseous fuel within a chamber of the fuel injector and injecting the gaseous fuel and atomized liquid fuel into the combustion chamber. The liquid fuel can be passed through and dispensed from a needle into a chamber in the injector nozzle where it is entrained in the gaseous fuel during an injection event. The liquid/gas mass ratio is controlled by the needle movement, hydraulic resistances or electronic valves so that the majority of the liquid is injected during the first part of the gas injection. The injector can be used for late cycle direct injection of natural gas, or any number of gaseous fuel blends combined with many liquid fuels such as diesel, biodiesel and DME.